US Stock MarketDetailed Quotes

Spero Therapeutics (SPRO)

Watchlist
  • 2.399
  • -0.001-0.04%
Trading Jan 16 14:33 ET
135.16MMarket Cap-3.04P/E (TTM)

Spero Therapeutics (SPRO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-61.02%3.05M
96.14%11.8M
21.57%5.11M
-71.68%27.4M
-86.97%9.36M
-66.56%7.82M
663.58%6.02M
468.11%4.2M
99.13%96.74M
54.95%71.83M
Operating revenue
-61.02%3.05M
96.14%11.8M
21.57%5.11M
-71.68%27.4M
-86.97%9.36M
-66.56%7.82M
663.58%6.02M
468.11%4.2M
99.13%96.74M
54.95%71.83M
Cost of revenue
Gross profit
Operating expense
-60.71%10.38M
-43.52%14.16M
8.14%19.67M
42.79%99.88M
41.85%30.2M
31.99%26.41M
83.35%25.08M
21.51%18.19M
-11.62%69.95M
3.88%21.29M
Selling and administrative expenses
-19.70%4.17M
6.24%5.88M
15.33%6.82M
-7.24%23.7M
9.68%7.06M
-8.93%5.2M
-9.24%5.53M
-19.13%5.92M
-29.96%25.55M
-0.95%6.43M
-General and administrative expense
-19.70%4.17M
6.24%5.88M
15.33%6.82M
-7.24%23.7M
9.68%7.06M
-8.93%5.2M
-9.24%5.53M
-19.13%5.92M
-29.96%25.55M
-0.95%6.43M
Research and development costs
-68.00%8.6M
-55.02%10.67M
-21.50%13.61M
88.10%96.76M
74.16%28.84M
63.87%26.86M
149.47%23.73M
93.03%17.33M
8.08%51.44M
9.73%16.56M
Other operating expenses
57.63%-2.39M
42.89%-2.39M
84.93%-763K
-192.09%-20.58M
-235.18%-5.69M
-170.21%-5.65M
-116.80%-4.18M
-280.96%-5.06M
-42.92%-7.05M
-56.12%-1.7M
Operating profit
60.58%-7.33M
87.61%-2.36M
-4.11%-14.56M
-370.59%-72.48M
-141.26%-20.85M
-651.39%-18.59M
-47.87%-19.06M
1.72%-13.98M
187.63%26.79M
95.43%50.53M
Net non-operating interest income expense
-54.99%532K
-38.23%740K
-34.89%864K
20.27%4.74M
-1.44%1.03M
24.42%1.18M
22.00%1.2M
37.80%1.33M
362.64%3.94M
45.87%1.04M
Non-operating interest income
-54.99%532K
-38.23%740K
-34.89%864K
20.27%4.74M
-1.44%1.03M
24.42%1.18M
22.00%1.2M
37.80%1.33M
255.97%3.94M
45.87%1.04M
Other net income (expense)
-2,150.00%-585K
-8,000.00%-79K
-1,142.86%-174K
84.64%-817K
-26,033.33%-778K
99.51%-26K
116.67%1K
-600.00%-14K
62.92%-5.32M
-98.49%3K
Special income (charges)
---587K
---83K
---175K
83.47%-877K
---877K
--0
--0
--0
54.38%-5.31M
--0
-Less:Restructuring and merger&acquisition
--0
--83K
--175K
--877K
--877K
--0
--0
--0
--0
----
-Less:Impairment of capital assets
--587K
----
----
--0
--0
--0
----
----
--5.31M
--0
-Write off
----
----
----
--0
--0
--0
----
----
--5.31M
--0
Other non- operating income (expenses)
107.69%2K
300.00%4K
107.14%1K
528.57%60K
3,200.00%99K
-160.00%-26K
116.67%1K
-600.00%-14K
99.61%-14K
100.08%3K
Income before tax
57.66%-7.38M
90.48%-1.7M
-9.45%-13.87M
-369.90%-68.57M
-139.94%-20.6M
-1,654.23%-17.44M
-49.92%-17.86M
4.50%-12.67M
154.73%25.4M
92.66%51.58M
Income tax
0
0
-25.06%290K
-113.12%-290K
2.6M
387K
Net income
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
Net income continuous Operations
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
Minority interest income
Net income attributable to the parent company
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
149.13%22.81M
91.22%51.19M
Basic earnings per share
59.38%-0.13
90.91%-0.03
-4.17%-0.25
-395.35%-1.27
-139.18%-0.38
-433.33%-0.32
-43.48%-0.33
4.00%-0.24
134.96%0.43
76.36%0.97
Diluted earnings per share
59.38%-0.13
90.91%-0.03
-4.17%-0.25
-395.35%-1.27
-139.18%-0.38
-433.33%-0.32
-43.48%-0.33
4.00%-0.24
134.96%0.43
76.36%0.97
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -61.02%3.05M96.14%11.8M21.57%5.11M-71.68%27.4M-86.97%9.36M-66.56%7.82M663.58%6.02M468.11%4.2M99.13%96.74M54.95%71.83M
Operating revenue -61.02%3.05M96.14%11.8M21.57%5.11M-71.68%27.4M-86.97%9.36M-66.56%7.82M663.58%6.02M468.11%4.2M99.13%96.74M54.95%71.83M
Cost of revenue
Gross profit
Operating expense -60.71%10.38M-43.52%14.16M8.14%19.67M42.79%99.88M41.85%30.2M31.99%26.41M83.35%25.08M21.51%18.19M-11.62%69.95M3.88%21.29M
Selling and administrative expenses -19.70%4.17M6.24%5.88M15.33%6.82M-7.24%23.7M9.68%7.06M-8.93%5.2M-9.24%5.53M-19.13%5.92M-29.96%25.55M-0.95%6.43M
-General and administrative expense -19.70%4.17M6.24%5.88M15.33%6.82M-7.24%23.7M9.68%7.06M-8.93%5.2M-9.24%5.53M-19.13%5.92M-29.96%25.55M-0.95%6.43M
Research and development costs -68.00%8.6M-55.02%10.67M-21.50%13.61M88.10%96.76M74.16%28.84M63.87%26.86M149.47%23.73M93.03%17.33M8.08%51.44M9.73%16.56M
Other operating expenses 57.63%-2.39M42.89%-2.39M84.93%-763K-192.09%-20.58M-235.18%-5.69M-170.21%-5.65M-116.80%-4.18M-280.96%-5.06M-42.92%-7.05M-56.12%-1.7M
Operating profit 60.58%-7.33M87.61%-2.36M-4.11%-14.56M-370.59%-72.48M-141.26%-20.85M-651.39%-18.59M-47.87%-19.06M1.72%-13.98M187.63%26.79M95.43%50.53M
Net non-operating interest income expense -54.99%532K-38.23%740K-34.89%864K20.27%4.74M-1.44%1.03M24.42%1.18M22.00%1.2M37.80%1.33M362.64%3.94M45.87%1.04M
Non-operating interest income -54.99%532K-38.23%740K-34.89%864K20.27%4.74M-1.44%1.03M24.42%1.18M22.00%1.2M37.80%1.33M255.97%3.94M45.87%1.04M
Other net income (expense) -2,150.00%-585K-8,000.00%-79K-1,142.86%-174K84.64%-817K-26,033.33%-778K99.51%-26K116.67%1K-600.00%-14K62.92%-5.32M-98.49%3K
Special income (charges) ---587K---83K---175K83.47%-877K---877K--0--0--054.38%-5.31M--0
-Less:Restructuring and merger&acquisition --0--83K--175K--877K--877K--0--0--0--0----
-Less:Impairment of capital assets --587K----------0--0--0----------5.31M--0
-Write off --------------0--0--0----------5.31M--0
Other non- operating income (expenses) 107.69%2K300.00%4K107.14%1K528.57%60K3,200.00%99K-160.00%-26K116.67%1K-600.00%-14K99.61%-14K100.08%3K
Income before tax 57.66%-7.38M90.48%-1.7M-9.45%-13.87M-369.90%-68.57M-139.94%-20.6M-1,654.23%-17.44M-49.92%-17.86M4.50%-12.67M154.73%25.4M92.66%51.58M
Income tax 00-25.06%290K-113.12%-290K2.6M387K
Net income 56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M
Net income continuous Operations 56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M
Minority interest income
Net income attributable to the parent company 56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M149.13%22.81M91.22%51.19M
Basic earnings per share 59.38%-0.1390.91%-0.03-4.17%-0.25-395.35%-1.27-139.18%-0.38-433.33%-0.32-43.48%-0.334.00%-0.24134.96%0.4376.36%0.97
Diluted earnings per share 59.38%-0.1390.91%-0.03-4.17%-0.25-395.35%-1.27-139.18%-0.38-433.33%-0.32-43.48%-0.334.00%-0.24134.96%0.4376.36%0.97
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More